Nigeria's $150M Vaccine Spending Expansion
Analysis based on 6 articles · First reported Apr 21, 2026 · Last updated Apr 22, 2026
Nigeria's annual spending of $150 million on vaccine procurement and the expansion of its malaria vaccination program indicate a significant investment in public health, which could positively impact the pharmaceutical and healthcare industries. The declining donor support from entities like GAVI suggests a growing reliance on domestic financing, potentially creating opportunities for local healthcare providers and manufacturers.
Nigeria's federal government spends approximately $150 million annually on vaccine procurement, as disclosed by Muyi Aina, Executive Director of the Nigeria — National Primary Health Care Development Agency. Funding is sourced from federal allocations and development partners such as GAVI, though donor support is declining, necessitating increased domestic financing. The spending covers procurement, outbreak response, and logistics for nationwide immunization. Nigeria has expanded its malaria vaccine rollout from pilot states Nigeria — Bayelsa State and Nigeria — Kebbi State to include Nigeria — Bauchi State and Nigeria — Ondo State. Challenges exist with the four-dose malaria vaccine schedule, leading to efforts to strengthen tracking systems. The country currently stores about 600,000 vaccine doses and has reached almost 1.3 million children with at least one dose. Vaccines are described as safe and cost-effective. Beyond immunization, Nigeria has provided free maternal services to 48,372 women and obstetric fistula repair services to 2,497 women through federal facilities and the Ghana — National Health Insurance Authority.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard